. The voltage dependence of block was unaffected, and a single binding site block model was used to describe block for all three ions. By varying ion species at the intra-and extracellular mouth of the channel and by using a nonconducting W472F-Kv1.5 mutant, we demonstrated that block was conditioned by the ion permeating the pore and, to a lesser extent, by the extracellular ion species alone. In Kv1.5, the outer pore mutations R487V and R487Y reduced nifedipine potency close to that of Kv4.2 and other Kv channels with an equivalent valine. Although changing this residue can affect C-type inactivation of Kv channels, the normalized reduction and time course of currents blocked by nifedipine in 5, 135, and 300 mM extracellular K ϩ concentration was the same. Similarly, a mean recovery time constant from nifedipine block of 316 ms was unchanged (332 ms) after 5-s prepulses to allow C-type inactivation. This is consistent with the conclusion that nifedipine block and C-type inactivation in the Kv1.5 channel can coexist but are mediated by distinct mechanisms coordinated by outer pore conformation. potassium channel; Kv4.2
potassium channel; Kv4.2 NIFEDIPINE HAS BEEN WIDELY USED for almost two decades in the control of cardiac chest pain and hypertension but has been associated, in a dose-dependent manner (10) , with unfavorable side effects like negative inotropy and hypotension, proarrhythmia, and (in some studies) increased mortality (10, 31) . This may occur especially with administration of short-acting forms of nifedipine in patients who are already hemodynamically compromised (13, 21) . Part of the mechanism for proarrhythmia caused by nifedipine may be the block of myocardial K ϩ channels, which has been described both in mammalian cardiac myocytes with equilibrium dissociation constants (K d ) of 0.5-1 M and in cloned channels (12, 32) . The plateau phase of the cardiac action potential is normally terminated by repolarizing outward potassium fluxes. Therefore, nifedipine block can prolong the action potential, cause a dispersion of refractoriness as these channels differ in their regional distribution across the myocardial wall (18) , and lead to instability of the resting potential of the muscle.
Despite the potential importance of these K ϩ channel actions of nifedipine, the mechanisms by which it exerts its actions on K ϩ channels are not fully defined. Many compounds block K ϩ channel currents by binding at or near the internal or external mouth of the ion-conducting pore, where they may act as direct open channel blockers by physically occluding the ion-conducting pore to prevent ion passage. Examples of this kind of blocker are quinidine and the quaternary ammonium compounds like tetraethylammonium (TEA), as well as the NH 2 -terminal inactivation particle in Shaker channels (8) . It is known that nifedipine acts as an open channel blocker of single Shaker mutant channels (1) and of the mammalian homolog Kv1.5 channels with a K d of 6.3 M (32). Whether nifedipine acts at the internal or external mouth of the K ϩ channel pore, though, is presently uncertain. Other details of the action of permeant ions on nifedipine block and the ability of the drug to bind to channel-inactivated states are also poorly understood. Kv channels show a rapid N-type inactivation or a slower C-type inactivation, affected by factors such as elevation of the extracellular K ϩ concentration ([K ϩ ] o ) (2, 20) , external application of TEA (6, 11) , and mutations of particular amino acids in the channel pore (7, 20, 24) . These effects have been incorporated into a physical model where C-type inactivation is caused by the constriction of the outer mouth of the channel pore in a cooperative action of all four subunits (30) , which restricts K ϩ flux (23, 24) . This rearrangement of the outer mouth of the pore greatly reduces the permeability of K ϩ relative to the permeability of Na ϩ , altering the ion selectivity of the channel (27) . Recently, it has been further proposed that, during C-type inactivation, the channels dwell in at least three conformational states: an initial open state that is highly selective for K ϩ , a state that is less permeable to K ϩ and more permeable to Na ϩ , and then a state that is nonconducting (17, 19) . Kv1.5 is a prominent cardiac K ϩ channel ␣-subunit because it is expressed in the human heart, particularly in the human atrium, and possibly in other regions of the human cardiovascular system (9, 28) . Nifedipine blocks Kv1. 5 as an open channel blocker with a K d of 6.3 M (32) . Here, we present evidence that the nature of the permeant ion does affect the dose dependence and kinetics of nifedipine block of Kv1.5 channels. This suggests that nifedipine block involves coupling between permeation and the blocking site and locates the binding of nifedipine within the permeation pathway of K ϩ channels. Outer pore mutations of R487 reduce the affinity for Kv1.5 channel block in manner consistent with other channels that have a valine residue at equivalent sites. We also show that nifedipine block, although affected by mutations similar to those known to affect outer pore C-type inactivation, can be shown to be kinetically separate from this slow inactivation process. This is based on nifedipine block of Kv1.5 carried out in different [K ϩ ] o and also on the effects of nifedipine on the recovery rates from C-type inactivation.
MATERIALS AND METHODS
Cell culture. Human Kv1.5 channels stably expressed in HEK-293 cell lines were used in all experiments. Kv1.5 in the plasmid expression vector pCDNA3 was mutagenized using the Quickchange Kit (Stratagene, La Jolla, CA) to convert arginine residue 487 to valine (R487V) or tyrosine (R487Y). HEK-293 cells were stably transfected with wild-type Kv1.5 or Kv1.5-R487(V/Y) cDNAs using LipofectACE reagent (Canadian Life Technologies, Bramalea, ON, Canada) in a 1-to-10 (wt/vol) ratio. Patch pipettes contained (in mM) 135 KCl, 5 EGTA, and 10 HEPES and were adjusted to pH 7.2 with KOH. When KCl was substituted with CsCl, RbCl, or N-methyl-D-glucamine (NMG ϩ ), the pH was adjusted with CsOH, RbOH, or HCl, respectively. The base bath solution contained (in mM) 135 NMG ϩ , 5 KCl, 10 HEPES, 1 MgCl 2 , and 1 CaCl 2 and was adjusted to pH 7.4 with HCl. For recordings in the presence of different external Cs ϩ , Rb ϩ , or K ϩ concentrations, the NMG ϩ base external solution was used, and KCl was substituted by the appropriate ions. The elevated external K ϩ solutions contained (in mM) 5, 135, or 300 KCl, 10 HEPES, and 1 MgCl 2 ; pH 7.4. Nifedipine was dissolved in ethanol at a stock concentration of 20 mM and was protected from exposure to light.
All chemicals were from Sigma Chemical (Mississauga, ON, Canada). The purity of NMG ϩ was 99-100.5% (by HCl titration, Sigma M2004). All water used in these experiments was passed through organic filters and two-stage distillation before a Milli-Q (Millipore) deionizing system returned the water at a specific resistance of ϳ20 M⍀. The contaminating K ϩ in the water used for solutions was below detection limits (Ͻ0.25 M) for coupled plasma optical emission spectroscopy (CANTEST Analytical Services, Vancouver, Canada), and the 140 mM NMG ϩ solution also had undetectable levels of K ϩ . The 135 mM Na ϩ solution gave a reading of 9.5 M K ϩ due to interference by the high Na ϩ concentration. Electrophysiological procedures. Coverslips containing cells were removed from the incubator before experiments and placed in a superfusion chamber (volume 250 l) containing the control bath solution at 22-23°C. The bath solution was exchanged by switching the perfusates at the inlet of the chamber, with complete bath solution changes taking 5-10 s. Whole cell current recording and data analysis were done using an Axopatch 200A amplifier and pCLAMP version 6.0 software (Axon Instruments, Foster City, CA). Patch electrodes were fabricated using thin-walled borosilicate glass (World Precision Instruments; Sarasota, FL). Capacity compensation and 80-95% series resistance compensation were routinely used. The averaged cell membrane capacitance was 15.1 Ϯ 0.5 pF, n ϭ 128, and measured series resistance was between 0.5-5.5 M⍀ for all recordings (averaged series resistance was 2.3 Ϯ 0.1 M⍀, n ϭ 128). When this changed during the course of an experiment, data were discarded. Data were filtered at 5-10 kHz and sampled at 10-20 kHz. Gating currents were recorded as described previously (29) . The data for analysis and presentation were off-line leak subtracted if required, and data were discarded if the leakage conductance was Ͼ1 nS. Throughout the text, data are shown as means Ϯ SE.
Data analysis. The concentration-response curves for permeating K ϩ , Rb ϩ , and Cs ϩ ions were computer fitted to the Hill equation
where f is the fractional current (I drug /I control ) at drug concentration D, IC 50 is the concentration producing half-maximal inhibition, and n H is the Hill coefficient. The time constant ( 2 ) of the rapid component of current decay in the presence of nifedipine was used as an approximation of the drug channel interaction kinetics, as described previously (4, 32) according to the equation
and
in which 2 is the current decay time constant caused by the drug, k ϩ1 and k Ϫ1 are the apparent rate constants of binding and unbinding for the drug, respectively, and K d represents the affinity of the drug for its binding site. The data for recovery from inactivation with a short initial depolarization were fit using a single-exponential equation
where A is the amplitude, t is the distance from the base of the curve, is the time constant for the rising phase of the curve, and C is the offset constant. Recovery from C-type inactivation (with a long inital pulse) and nifedipine block were fit using a double-exponential equation
in which 2 and 1 are the fast and slow time constants of current recovery or block, A 2 and A 1 are the corresponding amplitudes, and I indicates the noninactivating or nifedipine-insensitive current. Experimental values are given as means Ϯ SE. ANOVA and multiple pairwise comparison were used to test for significant differences between groups (Table 1 ). An unpaired t-test was used to compare off-gating current reduction with external or internal cations of each species. A value of P Ͻ 0.05 was considered statistically significant.
RESULTS

Nifedipine blocks K
ϩ , Rb ϩ , and Cs ϩ currents through Kv1.5 channels. The currents in Fig. 1 Fig. 1A were elicited from a holding potential of Ϫ80 mV to potentials between Ϫ30 and ϩ40 mV. In the control, the main difference between currents carried by the different ions was a decrease in current amplitude that reflected the decreased permeability of Rb ϩ or Cs ϩ compared with K ϩ and a reduction in the amount of slow C-type inactivation in Cs ϩ (8) , most visible at the more positive potentials. External application of 10 M nifedipine markedly inhibited both peak and steady-state K ϩ currents with an apparent acceleration in the decay rates of outward currents positive to ϩ10 mV (Fig. 1B) . The characteristics of nifedipine block of K ϩ currents through Kv1.5 channels have been previously studied in detail (32) . It is noticeable that the acceleration of current decay only becomes apparent at more positive potentials where the channel activation rate significantly exceeds the nifedipine block rate. At more negative potentials, block reduces current amplitude without significantly altering kinetics. External application of 10 M nifedipine also blocked Rb ϩ and Cs ϩ currents (Fig. 1B) , but the potency of block was significantly less. Application of 50 M nifedipine (Fig. 1C) produced a more marked block of current carried by all three cations and a significant acceleration of current decay that reflected open channel block caused by the drug. Steady-state current-voltage relations from these data are shown in Fig. 1D for the three ions and show the increased potency of nifedipine action when K ϩ was carrying current through Kv1. 5 potential, with a small reduction of block at more positive potentials.
The potency of nifedipine block was quantified in the dose-response curves shown in Fig. 2 Fig. 2A) . Hill coefficients close to 1.0 suggested a single binding site for nifedipine block of Kv1.5 no matter which ion species was permeating the channel. These results indicated that the potency of nifedipine block of Kv1.5 was not only dependent on nifedipine concentration but also strongly dependent on the permeating-ion species carrying Kv1.5 currents.
One of the noticeable features of the inhibition of Kv1.5 by nifedipine was the concentration-dependent increase in the apparent rate of current inactivation ( Fig. 1 ). In the control, the currents reached their peak at ϳ10 ms and then declined slowly. During 400-ms voltage pulses at ϩ40 mV, the currents could be fitted to a single exponential function (Eq. 3a) with a decay time constant of 214 Ϯ 17 ms (n ϭ 20), 297 Ϯ 20 ms (n ϭ 12), and 298 Ϯ 29 ms (n ϭ 9) for K ϩ , Rb ϩ , and Cs ϩ , respectively. In the presence of nifedipine, the peak current was reduced and reached at earlier times. The subsequent decay introduced an additional exponential component superimposed on the slow inactivation, so a biexponential function was used to fit the current decay in the presence of nifedipine (Eq. 3b). Between 5 and 50 M nifedipine, the time constants of the slow component of the current decay ( 1 ) are not significantly different from the control values (Table 1) , suggesting that the process of slow inactivation was not modified by nifedipine. The time constants of the initial fast-decaying component ( 2 ) decrease monotonically as a function of the nifedipine concentration (Table 1) . This extra fast component is at least 10 times faster than the slow inactivation. Therefore, the time constant ( 2 ) for this fast-decaying component was considered to be a reasonable approximation of the drugchannel interaction kinetics and was used to calculate the K d and on-and off-rates for nifedipine binding according to a single-site model (4 Fig. 2A and, therefore, support the applicability of a single-binding site model for nifedipine action on Kv1.5 with the three different permeant ions.
Membrane sideness of cation modulation of nifedipine action.
One of the primary aims of the present study was to determine the site of action of nifedipine on the Kv1.5 channels. Because the potency of block varied with different cation species permeating the channel, the following experiments were designed to concentration was kept constant at 130 mM, and the external ion concentration and species were changed to alter the direction of ion flow across the pore. A twopulse protocol was used, with an initial 200-ms prepulse to index block of Kv1.5 outward Cs ϩ current at ϩ80 mV by 20 M nifedipine and a 200-ms test pulse immediately afterward to ϩ30 mV to measure nifedipine block of current under different extracellular ion conditions (Fig. 3, A-D) . Mean currents measured at the end of the prepulse and the test pulse are shown in Table 2 . At the end of the 200-ms prepulse with an outward Cs ϩ current in all cases, there was no significant difference in the nifedipine block between extracellular Cs ϩ or K ϩ ( Table 2 ). During the test pulse at ϩ30 mV, as shown in Fig. 3 , A, C, and D, an outward Cs ϩ current is present, and there is little difference in the action of nifedipine.
The essential observation is shown in Fig. 3B with 70 mM [K ϩ ] o , where the inward K ϩ current at ϩ30 mV is significantly blocked by 20 M nifedipine. The current is inward at this potential due to the higher permeability of the pore for K ϩ than Cs ϩ . The current reduction is greater than that for any other ionic conditions (Table 2) and is the only condition where K ϩ is actually the permeating ion. In all other ionic conditions in these experiments, Cs ϩ is the permeating ion. These data support those in previous figures that indicated higher nifedipine potency with K ϩ in the bath and pipette rather than Cs ϩ . These data extend that idea to show that it is the pore ion species that determines nifedipine potency. When K ϩ is the permeating ion, as in Fig. 3B during the test pulse, the blocking action of Data are means Ϯ SE; n ϭ 3-13 cells. The Kv1.5 currents in the presence of nifedipine were fit by a double-exponential equation. The two time constants are shown with different concentrations of nifedipine. The time constants of the slow component ( 1 ) were not significantly different compared with the rapid time constants of Kv1.5 current decays ( 2 ) in the absence of nifedipine, which were fit with singleexponential equation (P Ͼ 0.05). nifedipine is enhanced compared with the prepulse when Cs ϩ is the pore-permeating ion. Nifedipine action on Kv1.5 mutant channels. The above experiments strongly support a pore-blocking action of nifedipine in Kv1.5. We wished to extend these experiments in a significant way by utilizing deep pore and outer pore mutants of Kv1.5. The first of these was a nonconducting mutant of Kv1.5, W472F. This single point mutant prevents ion permeation through the pore but otherwise gates normally, as demonstrated in Kv1.5 (5) and in Drosophila Shaker channels (25) . This mutant allows ions to be changed independently on each side of the membrane with the knowledge that they cannot cross the pore to influence nifedipine block on the other side. Nonconducting mutant function is measured by recording gating currents as an index of channel gating and opening, as we (15, 29) have shown before.
In these experiments, the cation species on each side of the membrane was changed independently and the action of nifedipine tested on the return of gating current (Ig off ) on repolarization. Channel block can be measured as a slowed return of gating charge on repolarization, because channel closing is slowed until the drug dissociates (32) . Such effects are clearly seen in the data in Fig. 4 . There is a prominent crossover of off-gating currents as they decay to the baseline in control and nifedipine treatments (e.g., Fig. 4 , A-C) as a result of slowed closing of the channel in the presence of drug. With K i ϩ or K o ϩ (Fig. 4, A and D) , the off-gating currents were greatly reduced and slowed in the presence of nifedipine, and the mean reduction of Ig off was significantly (P Ͻ
ϩ . The second mutant series that we have analyzed are changes to the outer mouth R487. This charged residue in Shaker channels is T449 (20) and is known to be a potent modulator of C-type inactivation as well as external TEA block in Shaker channels (14) . A number of these mutants failed to express measurable current when transiently transfected into HEK cells, but two notable mutants were R487V and R487Y. Interestingly, these two mutants were those found by LopezBarneo et al. (20) to most strongly inhibit the development of C-type inactivation. The effects of nifedipine on Cs ϩ , Rb ϩ , and K ϩ currents through R487V-Kv1.5 expressed in HEK cells are shown in Fig. 5 . At ϩ40 mV, it is immediately apparent that the effect of nifedipine was reduced in this mutant compared with the wildtype channel, where the IC 50 for inhibition of K ϩ current was 7.3 M. Similarly, nifedipine was a less po- Data are means Ϯ SE, n ϭ 6-12 cells. The normalized unblocked steady-state currents [current with nifedipine (I nif )/current in control (I ctrl )] left after the prepulse at 200 ms and after the second pulse to ϩ30 mV at 400 ms are from the data in Fig. 3 (Fig. 2) to ϳ1.6. The block of R487Y-Kv1.5 K ϩ currents by nifedipine was also tested. The IC 50 value was 21.6 Ϯ 0.4 M, and the Hill coefficient was 1.4 Ϯ 0.03 (n ϭ 6). These values are in close agreement with those obtained from the R487 mutant. It is known that these changes to the equivalent residue in Shaker channels result in quite local changes at the outer pore mouth and supports the idea that nifedipine effects on the channel depend on interactions in this outer mouth region of the channel.
Less potent action of nifedipine on Kv4.2 The observation that substitution of valine or tyrosine for arginine in the outer pore mouth of Kv1.5 reduced the IC 50 for nifedipine action significantly to ϳ20 M, which prompted us to examine other Kv channels with a valine at this position. In a Shaker B T449V mutant channel, an IC 50 of ϳ30 M was noted (1). The Shal channel Kv4.2 also has a valine at this equivalent position, and so we tested the ability of nifedipine to block this channel (Fig. 6) . The rat Kv4.2 gene was stably expressed in HEK cells, and currents were recorded in the whole cell configuration as for Kv1.5. The Kv4.2 gene encodes an A-type rapidly inactivating outward K ϩ current, and block by nifedipine can be measured as peak current reduction (as nifedipine block is of rapid onset) or as an overall reduction in charge during the pulse. When currents were integrated over time, we obtained charge records, as shown in Fig. 6B obtained from the current recordings in Fig. 6A . The concentration-response relations for peak current block and charge reduction by nifedipine are shown in Fig. 6C . Relations have similar IC 50 values of 32 and 29 M for peak current and charge reduction, respectively, with Hill coefficients of 0.9. We applied the same single binding site model to the Kv4.2 data as was applied to results from Kv1.5 (Fig. 2) . For Kv4.2 K ϩ currents, biexponential functions were required to fit the current decay both in the control and presence of nifedipine. As shown in Table 3 , the slow component of Kv4.2 inactivation was not changed with the addition of nifedipine, suggesting that the drug did not change the inactivation rate. However, the time constant of the initial fast component was decreased depending on drug concentration, suggesting an overlap between drug block and the initial fast inactivation component. If nifedipine block and inactivation are independent, the rate constants of the initial fast-decaying phase of Kv4.2 currents (1/ decay ) in the presence of nifedipine should be a sum of the rate constants of channel inactivation (1/ inactivation ) and of channel block (1/ block ) (26) as follows 1/ decay ϭ 1/ block ϩ 1/ inactivation (4) Thus the value of 1/ block can be estimated by subtracting 1/ inactivation from 1/ decay . Assuming the inactivation process was not changed by nifedipine, we calculated 1/ block and plotted it as a function of nifedipine concentration in Fig. 6D . We fit the data with Eq. 2a and extracted k ϩ1 (2.09 ϫ 10 6 M Ϫ1 ⅐ s Ϫ1 ), k Ϫ1 (57.9 s Ϫ1 ), and the K d (27.7 M) from the straight line fits. The K d value was in good agreement with that obtained from the concentration-response relation (Fig.  6C) and suggested that the assumption of the model ϩ current amplitudes but also apparently accelerated the decay rates of currents. These are shown clearly in Fig. 7A (inset) on an enlarged time scale. To clarify the relative rates of current decay, the current traces from Fig. 7A were normalized in Fig. 7B slowed) by the elevated external K ϩ concentration. Alternatively, extracellular K ϩ might directly influence nifedipine block. The nifedipine-sensitive currents shown in Fig. 7C were obtained by subtracting currents with nifedipine from currents in control. When normalized (as in Fig. 7D ), nifedipine-sensitive currents showed identical rates of decay. This was consistently observed in three other experiments with 20 M nifedipine and in experiments with lower and higher nifedipine concentrations. Nifedipine-sensitive currents were well fit by a single-exponential function (Eq. 3a), and the resulting time constants were 1,259 and 1,150 ms. Therefore, the different decay rates of currents after exposure to 20 M nifedipine shown in Fig. 7B resulted from different C-type inactivation kinetics caused by different K o ϩ concentrations rather than an alteration in the kinetics of nifedipine block.
The study was extended to test higher concentrations of K o ϩ , as shown in Fig. 8 ] o over this range on the amount of block induced by nifedipine. All these results are consistent with the idea that nifedipine block is a distinct process from C-type inactivation. This is further supported by our experiments on recovery from C-type inactivation.
Effects of nifedipine on recovery from C-type inactivation. To study recovery from C-type inactivation in the absence and presence of nifedipine, a double-pulse voltage protocol was used. The purpose of the first pulse (prepulse) was to predominantly activate (during short prepulses) or to activate and then inactivate the channel (during long prepulses). After a variable inter- A: currents during 400-ms voltage steps to ϩ40 mV from Ϫ80 mV. Currents were recorded in 5, 135, and 300 mM K o ϩ during exposure to 10 M nifedipine, and the tracings were normalized to peak current and superimposed. B: at different concentrations of K o ϩ , bars show relative block at the end of the voltage pulse. This was calculated from steady nifedipine block {1 Ϫ [steady-state current in nifedipine (ss Nif)/steady-state current in control (ss Ctrl)]}. Bars are means Ϯ SE (n ϭ 6-14 cells), and differences were not significant at the 5% level (one-way ANOVA). pulse duration, the second pulse (test pulse) was applied to test how many channels had recovered from the inactivated state induced by the prepulse. The fractional recovery was therefore defined as follows: fractional recovery ϭ I peak2 /I peak1 , where I peak1 and I peak2 represent the peak currents elicited by the preand test pulse depolarizations, respectively. The current traces shown in Fig. 9 were elicited by doublepulse protocols with long and short pulse durations over a range of interpulse intervals. All pulses were to ϩ40 mV. The holding potential and the potential during the interpulse intervals was Ϫ80 mV. The interval between each trace was 30 s to ensure that no inactivation accumulated between each cycle of the protocol.
In Fig. 9, A and B , the currents are in response to a long 5-s prepulse with interpulse intervals of variable duration from 180 ms to 3 s in increments of 400 ms. In the absence of nifedipine (Fig. 9A) , more than 50% of the current inactivated during the 5-s prepulse at ϩ40 mV. After a brief interval, peak current amplitudes recorded during test pulses (I peak2 ) were smaller than those of the first prepulse (I peak1 ). I peak2 recovered slowly with increasing interpulse intervals and reached only 85% of I peak1 after an interpulse interval of 3 s. When 20 M nifedipine was applied externally (Fig.  9B) , both peak and steady-state currents at ϩ40 mV were rapidly inhibited during the prepulse.
In the absence and presence of 20 M nifedipine, averaged fractional recovery was plotted against the interpulse intervals (Fig. 9E) . Control data points were well fit by a single-exponential function, with a mean recovery rate of 1.8 Ϯ 0.1 s (means Ϯ SE, n ϭ 8), which reflected the slow recovery from C-type inactivation. In the presence of 20 M nifedipine, data points were fit by a double-exponential equation, and the mean recovery rates were 2.8 Ϯ 0.3 s ( 1 ) and 0.33 Ϯ 0.02 s ( 2 ; means Ϯ SE, n ϭ 7). Although the slow time constants ( 1 ) in control and nifedipine are not in exact agreement, the data suggest that, in the presence of nifedipine, recovery after long depolarizations comprised two processes. One of these was the slow recovery from C-type inactivation ( 1 ) seen in the control and also still present, although somewhat slower, with nifedpine. The second additional fast recovery was likely to be recovery of noninactivated channels from open channel nifedipine block ( 2 ) during the repolarization (interpulse) interval. The initial rapid phase of recovery from block was small, and most of the recovery in the presence of nifedipine consisted of a slow recovery from C-type inactivation with a similar amplitude and time course to that observed in control. This clearly indicated that most of the channels rapidly blocked by nifedipine had subsequently inactivated during the prepulse (Fig. 9B) , and these channels recovered slowly. The fewer channels in the nifedipine-blocked but noninactivated state were able to recover rapidly on repolarization.
The separate nature of recovery from nifedipine block and C-type inactivation was further illustrated by applying a short double-pulse protocol, as indicated in Fig. 9C . Here, currents were elicited by pairs of 60-ms depolarizing pulses to ϩ40 mV with a variable interpulse interval from 120 to 1,920 ms in increments of 200 ms. The prepulse activated Kv1.5 channels and allowed nifedipine block while letting as few channels as possible become C-type inactivated. The data in Fig.  9C show that, in the absence of nifedipine, currents activated at ϩ40 mV minimally inactivated during the prepulse and were fully recovered after an interpulse interval of 120 ms. In the presence of 20 M nifedipine, current was significantly blocked during the 60-ms prepulse. Currents only partially recovered during test pulses after an interval of 120 ms. Mean data for fractional recovery during short double-pulse experiments are shown in Fig. 9F . The data points clearly showed that, in the absence of nifedipine, little inactivation occurred during the prepulse, and data could be fit using a straight line. In the presence of 20 M nifedipine, data were fit by a single-exponential equation to give a recovery rate of peak current from nifedipine block of 316 Ϯ 19 ms. Since little inactivation occurred over this duration, this time constant reflected the recovery from nifedipine block and was consistent with the faster of the two rates obtained from Fig. 9E (332 ms) . It seems, then, that whether inactivation was permitted [as during the long prepulse (Fig. 9, A and B) ] or not given time to develop during the short prepulse (Fig. 9, C and D) , nifedipine block and recovery occurred at the same rates. This strongly suggests that nifedipine block of Kv1.5 channels and C-type inactivation are independent processes.
DISCUSSION
Influence of permeating ions on Kv1.5 channel block by nifedipine. It has been reported before that permeating ions can affect the efficacy of channel block by charged drugs like TEA (3, 16) . In cloned Kv2.1 channels, external application of 30 mM TEA can block K ϩ currents by 87%, whereas the same external concentration of TEA has no effects on Na ϩ currents through the same channel (16) . Here, we have shown that, like TEA, nifedipine also has a different potency for block of K ϩ , Rb ϩ , and Cs ϩ currents through another Kv channel, Kv1.5 ( Figs. 1 and 2 ). Because TEA block is coordinated by all four K ϩ channel subunits, although Na ϩ ions are smaller than K ϩ , it seems most likely that binding of K ϩ rather than Na ϩ within the permeation pathway allows the formation of the TEA or nifedipine binding sites. Alternatively, it is possible that nifedipine binds with the same affinity to channels that pass both K ϩ and Cs ϩ and that the larger cation can more easily escape the blocker and pass through the channels. The pore configuration that would allow this possibility is uncertain, and the data in Fig. 3B showed increasing block of the inward current during the switch from outward Cs ϩ to inward K ϩ current. This suggests that the nifedipine binding affinity was different in the presence of different ions.
When K ϩ , Rb ϩ , and Cs ϩ ions permeate through Kv1.5 channels, their different sizes induce unique conformational changes in the structure of the pore that might affect the binding site of nifedipine itself or the ability of nifedipine to access such a site. In the latter case, the binding site(s) of permeating ions within the channel pore could be close to the binding site of nifedipine, and the larger cations might affect access of nifedipine to its binding site by steric hindrance. We (32) had previously reported that nifedipine blocked Kv1.5 with an apparent distance of 12-16% of the electric field from the outside. It was shown in Fig. 1 that there was no obvious change in the voltage dependence of block with the three different cations, which suggests that the site of action of nifedipine in the outer pore mouth had not significantly moved. A single-binding site model was still appropriate to describe the kinetics of nifedipine block by the three different cations. The slopes of the concentrationresponse relations had Hill coefficients close to 1.0 (Fig.  2) , and the concentration dependence of the acceleration of current decay by the drug produced values for on-and off-drug binding rates and K d that closely fitted a single site model. This also validated an open-channel block mechanism by nifedipine in the presence of the three different cations.
Site of nifedipine action on Kv1.5. Nifedipine action on Kv1.5 appears to be closely tied to the ion conduction pathway. The drug does not block closed channels but rapidly blocks open channels causing a rapid current decay superimposed on slower inactivation when activation is sufficiently rapid to allow this to be seen (Fig. 1) . The influence of different permeating cations on the rate and potency of the block of ionic and gating currents is further evidence for effects within the open pore. In conducting channels, when K ϩ was the permeating cation (as in Fig. 3B at ϩ30 mV), block was more extensive than when Cs ϩ was the permeating cation. Overall, the data showed that the permeating cation was the most important determinant of block (Table 1) . When ion permeation was prevented in the W472F nonconducting mutant and gating currents were measured (Fig. 4) , it was shown that extracellular K ϩ allows greater block of Kv1.5 by nifedipine than other extracellular cations. Interestingly, though, in these experiments, addition of only intracellular K ϩ or Rb ϩ was able to coordinate a relatively potent block of off-gating current by nifedipine. This suggested that even intracellular ions were able to have long range effects on overall pore conformation and affect the formation of the nifedipine binding site in the outer channel mouth without being present there. Pore mutants and their effects. Two outer pore mutants of Kv1.5, R487V and R487Y, affected the concentration dependence of nifedipine block of the channel. Low concentrations of nifedipine were much less effective on these mutant channels regardless of the ionic species, but there was a steepening of the concentration-response relationships so that at higher concentrations nifedipine apparently blocked the channel to the same degree as the wild-type channels, and the overall efficacy was unchanged (Fig. 5) . The ion-dependent shift in the IC 50 of the concentration-response relations was maintained but reduced in relative terms, so that whereas Cs ϩ was 4 times less potent in the wild-type channels, it was 2.5 times less potent in the R487V mutant. This result suggested that the ion effects on nifedipine potency could be separated to a large degree from effects of outer pore mutations on nifedipine binding to Kv1.5 and that ion species effects were not caused by interaction directly at the nifedipine binding site. This argues against a common site for nifedipine block and ion modulation of block in Kv1.5.
The steepening of the concentration-response relations in the R487V mutant increased the Hill coefficients from ϳ1 to ϳ1.6 and suggested that the muta-tion was able to significantly alter the mechanism by which nifedipine binds to Kv1.5. It is possible that substitution of the positively charged arginine by the hydrophobic valine or the planar ring of tyrosine facilitates additional molecules of nifedipine binding to the channel, perhaps forming another binding site for nifedipine. Overall affinity is reduced as evidenced by the decreased potency, but once a raised nifedipine concentration is present at the outer pore mouth, it is possible that the binding of a second nifedipine is facilitated, and channel block is enhanced. The valine substitution in Shaker channels results in a similar potency to that in Kv1.5 (1), and a similarly low potency was observed in our experiments in Kv4.2 channels, which have a valine at the equivalent site to R487 in Kv1.5 (Fig. 6) . In this situation, though, the presence of valine per se does not confer a cooperative action of nifedipine, and the concentration-response relation had a Hill coefficient close to 1.0.
Nifedipine block and C-type inactivation. The principal action of nifedipine on Kv1.5 was to accelerate the rate of current decay once the channel-opening rate significantly exceeded blocking rate. The possibility existed, because permeant cations modulated the degree of nifedipine block, that the action of nifedipine was in some way related to an acceleration of C-type inactivation. This is based on the knowledge that permeant cations, and especially extracellular cation concentrations, are effective modulators of the rate of C-type inactivation (20) and the recovery from inactivation. In addition, the residue R487 in Kv1.5 is analogous to T449 in Shaker channels in that both are important determinants of the inactivation rate. In Kv1.5, though, the role for this residue is less critical (8) , and, as discussed below, quite large changes in [K ϩ ] o have less pronounced effects on the inactivation rate than in Shaker channels. Modulation of C-type inactivation by channel blockers has been extensively studied by internal or external applications of TEA, where external TEA competes for C-type inactivation (6, 11) . Interactions between C-type inactivation and channel blockers are manifested in many ways. In Kv1.3 channels in T lymphocytes, slowed C-type inactivation via exposure to 160 mM [K ϩ ] o greatly diminished the potency of CP-339,818, a channel blocker of Kv1.3 (22) , suggesting that CP-339,818 preferentially bound to the inactivated state of Kv1.3. In mutant ShB ⌬6-46 expressed in Xenopus oocytes, nifedipine block was found to be insensitive to [K ϩ ] o (1), suggesting that it could be separated from C-type inactivation.
We were able to clearly demonstrate that nifedipine block and recovery from block are not coupled to the process of C-type inactivation. Increased [K ϩ ] o slowed C-type inactivation of Kv1.5 channels (Fig. 7) , consistent with observations in ShB expressed in Xenopus oocytes (20) and Kv1.3 in T lymphocytes (22) . These results implied that the mechanistic basis for C-type inactivation occurring in these different channels is similar. However, the time courses of net currents and level of block by nifedipine were unchanged by in- (Figs. 7 and 8) . The proportion of channels undergoing C-type inactivation was not greatly different before and after nifedipine, as evidenced by the difference in decay of normalized records in 5 and 135 mM [K ϩ ] o in Fig. 7B . This suggests that nifedipineinduced current decay and C-type inactivation were mediated by distinct mechanisms, but both coexisted in the presence of nifedipine.
On the basis of the observation that onset of nifedipine block was much faster than development of C-type inactivation, we expected that recovery from nifedipine block should be much faster than from C-type inactivation. This also allowed a test of whether nifedipineblocked channels subsequently C-type inactivated and thus recovered slowly. If both processes were independent, they should be distinguished by their apparently different recovery rates. The experiments indicated that nifedipine-blocked channels could freely C-type inactivate and also that the unchanged fast time constant of recovery in the presence or absence of C-type inactivation supported the separate nature of unblock and C-type inactivation. Overall, the experiments indicate that the outer pore mouth block is mediated at a nifedipine binding site that is relatively unaffected by the processes involved in the onset and development of C-type inactivation in this channel.
